Insider and congress filings
Eli Lilly and Company (LLY)
About Eli Lilly and Company
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- David A. Ricks
- Employees
- 50,000
- Listed since
- -
- Market value
- $1.1T
- Price to earnings
- 37.7
- Earnings per share
- $29.93
- Dividend yield
- 0.60%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $8.38 | $6.40 | $23.0B | $20.8B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $8.55 | $6.97 | $19.8B | $17.8B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 4, 2026 | $7.54 | $6.91 | $19.3B | $17.9B | EPS beatRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $7.02 | $5.69 | $17.6B | $16.1B | EPS beatRevenue beat |
| Q2 FY2025reported Aug 7, 2025 | $6.31 | $5.60 | $15.6B | $14.7B | EPS beatRevenue beat |
| Q1 FY2025reported May 1, 2025 | $3.34 | $3.26 | $12.7B | $12.7B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 20, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| David A. RicksChair, President, and Chief Executive Officer | $1.7M | $23.3M | $11.7M | $36.7M |
| Daniel M. SkovronskyM.D., Ph.D. Executive Vice President, Chief Scientific | $1.5M | $12.0M | $4.3M | $17.8M |
| Anat HakimExecutive Vice President, General Counsel and Secretar | $1.0M | $6.0M | $2.8M | $9.8M |
| Lucas MontarceExecutive Vice President and Chief Financial Officer | $1.0M | $5.0M | $2.5M | $8.5M |
| Jake Van NaardenExecutive Vice President and President, Lilly Oncology | $920K | $4.5M | $2.2M | $7.6M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Lilly Endowment Inc | $108.4B | 90,376,978 | -1.7% | 10.13% |
| Blackrock, Inc. | $81.0B | 67,540,400 | +1.7% | 7.57% |
| Vanguard Capital Management LLC | $64.2B | 53,528,868 | +0.3% | 6.00% |
| PNC Financial Services Group, Inc. | $61.6B | 51,322,720 | -0.0% | 5.75% |
| State Street Corp | $43.4B | 36,215,754 | +1.7% | 4.06% |
| FMR LLC | $34.1B | 28,462,475 | +8.1% | 3.19% |
| Capital Research Global Investors | $25.0B | 20,873,140 | -15.3% | 2.34% |
| Vanguard Portfolio Management LLC | $25.0B | 20,859,217 | -0.6% | 2.34% |
| Geode Capital Management, LLC | $24.3B | 20,310,858 | +0.6% | 2.28% |
| Morgan Stanley | $19.5B | 16,226,398 | +5.1% | 1.82% |
| Capital World Investors | $19.1B | 15,902,642 | +1.8% | 1.78% |
| Price T Rowe Associates Inc | $16.7B | 13,911,839 | -0.6% | 1.56% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
5 filings of 406 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Patrik JonssonEVP & President, LLY Int'l | Sold | 6,500 | $1175.10 | $7.6M | Aug 17, 2026 | 1d |
| Donald A. ZakrowskiSVP, Finance, & CAO | Sold | 2,000 | $1185.01 | $2.4M | Aug 10, 2026 | 1d |
| Anat HakimEVP, GC & Secretary | Sold | 5,000 | $1190.00 | $6.0M | Aug 7, 2026 | 3d |
| Ilya YuffaEvp&pres, LLY Usa&global Capab | Sold | 2,500 | $1150.77 | $2.9M | Jun 10, 2026 | 1d |
| Lilly Endowment Inc | Sold · 2 lines | 15,828 | $995.36 | $15.8M | May 6, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in LLY
20 disclosures of 196 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael A. RulliFiled late | Stock | Sale | $1,001 - $15,000 | +7.7%S&P +12.0% · vs S&P 500 -4.3% | Dec 2, 2025 | Aug 7, 2026 | 248d |
| Michael A. RulliFiled late | Stock | Purchase | $1,001 - $15,000 | +4.3%S&P +11.7% · vs S&P 500 -7.4% | Jan 2, 2026 | Aug 7, 2026 | 217d |
| Michael A. Rulli | Stock | Sale | $1,001 - $15,000 | -5.4%S&P +2.4% · vs S&P 500 -7.8% | Jul 1, 2026 | Aug 7, 2026 | 37d |
| Alan ArmstrongSelfFiled late | Stock | Sale (Full) | $1,001 - $15,000 | +28.0%S&P +20.2% · vs S&P 500 +7.8% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Dan NewhouseSpouse | Stock | Sale | $1,001 - $15,000 | -5.4%S&P +1.0% · vs S&P 500 -6.4% | Jul 10, 2026 | Jul 17, 2026 | 7d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +5.6%S&P +0.4% · vs S&P 500 +5.3% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $50,001 - $100,000 | -1.1%S&P +5.1% · vs S&P 500 -6.1% | Jun 10, 2026 | Jul 2, 2026 | 22d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +16.7%S&P +5.8% · vs S&P 500 +10.9% | May 1, 2026 | Jun 9, 2026 | 39d |
| Byron DonaldsSpouse | Stock | Purchase | $1,001 - $15,000 | +20.2%S&P +16.2% · vs S&P 500 +3.9% | Apr 2, 2026 | May 13, 2026 | 41d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +20.9%S&P +11.1% · vs S&P 500 +9.8% | Apr 13, 2026 | May 11, 2026 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +21.9%S&P +9.8% · vs S&P 500 +12.1% | Apr 14, 2026 | May 8, 2026 | 24d |
| Lizzie Fletcher | Stock | Sale | $1,001 - $15,000 | +17.9%S&P +12.8% · vs S&P 500 +5.1% | Apr 8, 2026 | May 1, 2026 | 23d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +14.1%S&P +15.1% · vs S&P 500 -0.9% | Mar 13, 2026 | Apr 7, 2026 | 25d |
| Angus S. King Jr.Spouse | Stock | Sale (Full) | $1,001 - $15,000 | +8.1%S&P +11.8% · vs S&P 500 -3.7% | Feb 13, 2026 | Mar 24, 2026 | 39d |
| David Taylor | Stock | Purchase | $1,001 - $15,000 | +10.0%S&P +10.6% · vs S&P 500 -0.6% | Feb 26, 2026 | Mar 6, 2026 | 8d |
| David Taylor | Stock | Sale | $1,001 - $15,000 | +7.6%S&P +9.8% · vs S&P 500 -2.2% | Feb 9, 2026 | Feb 20, 2026 | 11d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +5.6%S&P +10.6% · vs S&P 500 -4.9% | Jan 23, 2026 | Feb 6, 2026 | 14d |
| David Taylor | Stock | Sale | $1,001 - $15,000 | +8.3%S&P +10.2% · vs S&P 500 -1.9% | Jan 16, 2026 | Feb 2, 2026 | 17d |
| Angus S. King Jr.Spouse | Stock | Purchase | $1,001 - $15,000 | +4.2%S&P +10.8% · vs S&P 500 -6.6% | Dec 29, 2025 | Jan 26, 2026 | 28d |
| Markwayne MullinJoint | Stock | Purchase | $15,001 - $50,000 | +4.5%S&P +11.0% · vs S&P 500 -6.5% | Dec 29, 2025 | Jan 16, 2026 | 18d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
16 members · estimate, as of Sep 10, 202616 members report a position (estimated). The largest estimated position is in the $500,001 - $1,000,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| J. French Hill | Republican · House | $500,001 - $1,000,000 | 4.7% |
| Markwayne Mullin | Republican · Senate | $250,001 - $500,000 | 1.1% |
| Robert Bresnahan | Republican · House | $100,001 - $250,000 | 1.3% |
| Sheldon Whitehouse | Democrat · Senate | $100,001 - $250,000 | 0.6% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $100,001 - $250,000 | 0.4% |
| Josh Gottheimer | Democrat · House | $50,001 - $100,000 | 0.3% |
| Julie Johnson | Democrat · House | $50,001 - $100,000 | 0.6% |
| Steve Cohen | Democrat · House | $50,001 - $100,000 | 2.1% |
| Jared Moskowitz | Democrat · House | $50,001 - $100,000 | 1.1% |
| Marjorie Taylor Greene | Republican · House | $15,001 - $50,000 | 1.1% |
| Byron Donalds | Republican · House | $15,001 - $50,000 | 4.2% |
| John Boozman | Republican · Senate | $15,001 - $50,000 | 0.7% |
| Ron Wyden | Democrat · Senate | $1,001 - $15,000 | 0.1% |
| Shelley Moore Capito | Republican · Senate | $1,001 - $15,000 | 0.4% |
| John McGuire | Republican · House | $1,001 - $15,000 | 1.8% |
| Tony Wied | Republican · House | $1,001 - $15,000 | <0.1% |
A further 2 members report a position estimated under $1,000; those are not listed.
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Eric DozierEVP, Chief People Officer | Gift | 216 | Sep 2, 2026 |
| Edgardo HernandezEVP & Pres., Mfg. Operations | Gift | 13 | Sep 2, 2026 |
| Gabrielle SulzbergerDirector | Stock award | 4 | Aug 17, 2026 |
| Ralph AlvarezDirector | Stock award | 10 | Aug 17, 2026 |
| J. Erik FyrwaldDirector | Stock award | 8 | Aug 17, 2026 |
| Juan R. LucianoDirector | Stock award | 13 | Aug 17, 2026 |
| Melissa SeymourEVP, Global Quality | Tax withholding | 439 | Aug 1, 2026 |
| Melissa SeymourEVP, Global Quality | Option exercise | 981 | Aug 1, 2026 |
| Ralph AlvarezDirector | Stock award | 22 | Jul 20, 2026 |
| J. Erik FyrwaldDirector | Stock award | 17 | Jul 20, 2026 |
| Gabrielle SulzbergerDirector | Stock award | 9 | Jul 20, 2026 |
| Juan R. LucianoDirector | Stock award | 28 | Jul 20, 2026 |
| J. Erik FyrwaldDirector | Stock award | 18 | Jun 15, 2026 |
| Ralph AlvarezDirector | Stock award | 22 | Jun 15, 2026 |
| Juan R. LucianoDirector | Stock award | 28 | Jun 15, 2026 |
| Gabrielle SulzbergerDirector | Stock award | 9 | Jun 15, 2026 |
| J. Erik FyrwaldDirector | Stock award | 20 | May 18, 2026 |
| Ralph AlvarezDirector | Stock award | 25 | May 18, 2026 |
| Juan R. LucianoDirector | Stock award | 32 | May 18, 2026 |
| Gabrielle SulzbergerDirector | Stock award | 10 | May 18, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling LLY?
Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales.
Which members of Congress have traded LLY?
Michael A. Rulli, Alan Armstrong, Dan Newhouse, Ro Khanna, Gilbert Ray Cisneros, Jr., Byron Donalds and others disclosed LLY transactions in the filings shown here.
Which members of Congress hold LLY?
16 members of Congress report a position in LLY in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to J. French Hill, Markwayne Mullin and Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is LLY in the S&P 500 or the Nasdaq 100?
Eli Lilly and Company is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are LLY trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.